Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Mask Maker Warned for Unapproved Device

  • Post author:Sam
  • Post published:March 6, 2020
  • Post category:The GMP Letter

The FDA hit Phoenix, Arizona-based devicemaker CPAPNEA Medical Supply with a warning letter for marketing a device without premarket approval. Source: The GMP Letter

Continue ReadingMask Maker Warned for Unapproved Device

Rhode Island Firm Draws Warning for Design Controls

  • Post author:Sam
  • Post published:March 6, 2020
  • Post category:The GMP Letter

Rhode Island device manufacturer Unetixs Vascular drew an FDA warning letter for failing to meet design requirements for its MultiLab Series ROODRA vascular diagnostic system. Source: The GMP Letter

Continue ReadingRhode Island Firm Draws Warning for Design Controls

No Reported Device Shortages From Coronavirus Outbreak, FDA Says

  • Post author:Sam
  • Post published:March 6, 2020
  • Post category:The GMP Letter

FDA Commissioner Stephen Hahn said that the agency is not aware of any medical device shortages connected to the outbreak of the novel coronavirus — but the agency is aware…

Continue ReadingNo Reported Device Shortages From Coronavirus Outbreak, FDA Says

FDA Allows Early Release of COVID-19 Diagnostics

  • Post author:Sam
  • Post published:March 6, 2020
  • Post category:The GMP Letter

The FDA issued a new policy that will allow certain laboratories to use validated COVID-19 diagnostics while the agency reviews their Emergency Use Authorization (EUA) requests. Source: The GMP Letter

Continue ReadingFDA Allows Early Release of COVID-19 Diagnostics

WHO Considers Unit-Level Serial Numbers for Drug Tracking

  • Post author:Sam
  • Post published:March 3, 2020
  • Post category:Drug GMP Report

The World Health Organization (WHO) is seeking comments by February 28 on a draft policy on tracking and tracing drugs through the supply chain that would push globally for unit-level…

Continue ReadingWHO Considers Unit-Level Serial Numbers for Drug Tracking

483 Roundup: FDA Cites Seven Firms for GMP, Quality Lapses

  • Post author:Sam
  • Post published:March 3, 2020
  • Post category:Drug GMP Report

The FDA hit drugmakers in China, South Korea, India and Germany for numerous GMP and other violations observed during agency inspections. Source: Drug GMP Report

Continue Reading483 Roundup: FDA Cites Seven Firms for GMP, Quality Lapses

Warning Letters: FDA Warns Drugmakers in China and Germany

  • Post author:Sam
  • Post published:March 3, 2020
  • Post category:Drug GMP Report

The FDA issued warning letters to drug manufacturing facilities in China and Germany for lax testing, recordkeeping and other failures. Source: Drug GMP Report

Continue ReadingWarning Letters: FDA Warns Drugmakers in China and Germany

Pharma Companies Support Use of Blockchain for Drug Tracking

  • Post author:Sam
  • Post published:March 3, 2020
  • Post category:Drug GMP Report

A blockchain-based drug tracking network is capable of meeting future supply chain regulatory requirements, according to pharma companies that took part in a pilot program run by the FDA. Source:…

Continue ReadingPharma Companies Support Use of Blockchain for Drug Tracking

Coronavirus Outbreak: Former FDA Commissioner, API Manufacturers Call for Action

  • Post author:Sam
  • Post published:March 3, 2020
  • Post category:Drug GMP Report

Former FDA Commissioner Scott Gottlieb warned of the potential for “unprecedented supply chain disruptions” as the COVID-19 outbreak threatens China’s production of starting materials. The agency reported the first coronavirus-related…

Continue ReadingCoronavirus Outbreak: Former FDA Commissioner, API Manufacturers Call for Action

Ireland’s NSAI Becomes 11th Notified Body Under EU MDR

  • Post author:Sam
  • Post published:February 24, 2020
  • Post category:Devices & Diagnostics Letter

NSAI said it will begin accepting applications for conformity assessment activities from April 1, 2020. Source: Devices & Diagnostics Letter

Continue ReadingIreland’s NSAI Becomes 11th Notified Body Under EU MDR
  • Go to the previous page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.